Loading company details...
Latest Form 4 (Nov 19, 2026): Faraz Ali (Chief Executive Officer): Sale of 3,499 shares, $1.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 19, 2026 | Faraz Ali, Chief Executive Officer | Sale | 3,499 | $1.1K |
| Nov 19, 2026 | Whittemore Tingley, Chief Medical Officer | Sale | 3,223 | $1.0K |
| Sep 12, 2026 | Faraz Ali, Chief Executive Officer | Grant/Award | 122,000 | n/a |
| Sep 12, 2026 | Whittemore Tingley, Chief Medical Officer | Grant/Award | 49,000 | n/a |
| Aug 18, 2026 | Faraz Ali, Chief Executive Officer | Sale | 5,837 | $4.1K |
| Aug 18, 2026 | Whittemore Tingley, Chief Medical Officer | Sale | 1,637 | $1.2K |
| Jul 15, 2026 | Eric J. Hyllengren, Chief Financial Officer | Grant/Award | 1,650,000 | n/a |
| May 29, 2026 | R. Sanders Williams | Grant/Award | 120,000 | n/a |
| May 29, 2026 | Jeffrey T. Walsh | Grant/Award | 120,000 | n/a |
| May 29, 2026 | Catherine Stehman-Breen | Grant/Award | 120,000 | n/a |